Presentation is loading. Please wait.

Presentation is loading. Please wait.

A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer  Sandro Pignata, Enrico.

Published byPaolina Rachele Corsini Modified over 6 years ago

Similar presentations

Presentation on theme: "A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer  Sandro Pignata, Enrico."— Presentation transcript:

1 A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer  Sandro Pignata, Enrico Breda, Giovanni Scambia, Carmela Pisano, Vittorina Zagonel, Domenica Lorusso, Stefano Greggi, Rocco De Vivo, Gabriella Ferrandina, Ciro Gallo, Francesco Perrone  Critical Reviews in Oncology / Hematology  Volume 66, Issue 3, Pages (June 2008) DOI: /j.critrevonc Copyright © 2008 Elsevier Ireland Ltd Terms and Conditions

2 Fig. 1 Baseline geriatric evaluation.
Critical Reviews in Oncology / Hematology  , DOI: ( /j.critrevonc ) Copyright © 2008 Elsevier Ireland Ltd Terms and Conditions

Download ppt "A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer  Sandro Pignata, Enrico."

Similar presentations

Advances in shaking technologies Wolf Klöckner, Jochen Büchs Trends in Biotechnology Volume 30, Issue 6, Pages 307-314 (June 2012) DOI: 10.1016/j.tibtech.2012.03.001.

Advances in shaking technologies Wolf Klöckner, Jochen Büchs Trends in Biotechnology Volume 30, Issue 6, Pages (June 2012) DOI: /j.tibtech
Perimenopausal migraine in women with vasomotor symptoms E. Anne MacGregor Maturitas Volume 71, Issue 1, Pages 79-82 (January 2012) DOI: 10.1016/j.maturitas.2011.11.001.

Perimenopausal migraine in women with vasomotor symptoms E. Anne MacGregor Maturitas Volume 71, Issue 1, Pages (January 2012) DOI: /j.maturitas
The Survival Kit: Software to analyze survival data including possibly correlated random effects G. Mészáros, J. Sölkner, V. Ducrocq Computer Methods and.

The Survival Kit: Software to analyze survival data including possibly correlated random effects G. Mészáros, J. Sölkner, V. Ducrocq Computer Methods and.
Treatment of HER2 positive advanced breast cancer with T-DM1: A review of the literature María Teresa Martínez, José Alejandro Pérez-Fidalgo, Paloma Martín-Martorell,

Treatment of HER2 positive advanced breast cancer with T-DM1: A review of the literature María Teresa Martínez, José Alejandro Pérez-Fidalgo, Paloma Martín-Martorell,
Metastatic melanoma treatment: Combining old and new therapies Ryan J. Davey, Andre van der Westhuizen, Nikola A. Bowden Critical Reviews in Oncology /

Metastatic melanoma treatment: Combining old and new therapies Ryan J. Davey, Andre van der Westhuizen, Nikola A. Bowden Critical Reviews in Oncology /
Influence of maternal nicotine exposure during gestation and lactation on lactate dehydrogenase isoenzyme profile and transcript levels in developing neonatal.

Influence of maternal nicotine exposure during gestation and lactation on lactate dehydrogenase isoenzyme profile and transcript levels in developing neonatal.
Eribulin—A review of preclinical and clinical studies

Eribulin—A review of preclinical and clinical studies
Gastric cancer Critical Reviews in Oncology / Hematology

Gastric cancer Critical Reviews in Oncology / Hematology
Umesh K. Narta, Shamsher S. Kanwar, Wamik Azmi 

Umesh K. Narta, Shamsher S. Kanwar, Wamik Azmi 
Exercise issues in older cancer survivors

Exercise issues in older cancer survivors
Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review  Cloé Brami, Ting Bao, Gary Deng  Critical.

Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review  Cloé Brami, Ting Bao, Gary Deng  Critical.
Novel targets in gastric and esophageal cancer

Novel targets in gastric and esophageal cancer
Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Bevacizumab in First-line Patients with Advanced Nonsquamous Non-small Cell.

Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Bevacizumab in First-line Patients with Advanced Nonsquamous Non-small Cell.
Critical Reviews in Oncology / Hematology

Critical Reviews in Oncology / Hematology
Nicoletta Colombo, Martin Gore 

Nicoletta Colombo, Martin Gore 
Invasive lobular breast cancer and its variants: How special are they for systemic therapy decisions?  Séverine Guiu, Anita Wolfer, William Jacot, Pierre.

Invasive lobular breast cancer and its variants: How special are they for systemic therapy decisions?  Séverine Guiu, Anita Wolfer, William Jacot, Pierre.
Volume 47, Issue 12, Pages (December 2011)

Volume 47, Issue 12, Pages (December 2011)
Philipp Dahm, Ari D. Silverstein, Alon Z

Philipp Dahm, Ari D. Silverstein, Alon Z
MITO (Multicentre Italian Trials in Ovarian cancer) - CERV2 trial: a randomized phase II study of carboplatin and paclitaxel +/- cetuximab, in advanced.

MITO (Multicentre Italian Trials in Ovarian cancer) - CERV2 trial: a randomized phase II study of carboplatin and paclitaxel +/- cetuximab, in advanced.
Organization of the clinical activity of Geriatric Oncology: Report of a SIOG (International Society of Geriatric Oncology) task force  Silvio Monfardini,

Organization of the clinical activity of Geriatric Oncology: Report of a SIOG (International Society of Geriatric Oncology) task force  Silvio Monfardini,

Similar presentations

Ads by Google